This novel gene therapy showed enhanced apoptotic activity in vitro across a variety of p53-mutated ovarian cancer cell lines, indicating that it could be utilized as a treatment regardless of p53 status [104], and it more recently showed tumor suppression in a zebrafish model of liver cancer [166]. The gene discussed is TP53; the disease is ovarian carcinoma.